2,3,4,5-Tetrahydro-2,2'-bipyridine | 64040-84-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2,3,4,5-Tetrahydro-2,2'-bipyridine
• 英文别名: 2-(2,3,4,5-tetrahydropyridin-2-yl)pyridine
• CAS: 64040-84-2
• 化学式: C₁₀H₁₂N₂
• 分子量: 160.22
• InChiKey: VFZDBPCXSHSRNF-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  12
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  25.2
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Pyrrolopyrimidines and Pyrrolopyridines
  申请人：Leblanc Catherine

  公开号：US20090181941A1

  公开（公告）日：2009-07-16

  Compounds of formula I in free or salt or solvate form, wherein X, T 1 , T 3 and T 4 have the meanings as indicated in the specification, are useful for treating diseases mediated by the ALK-5 and/or ALK-4 receptor. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.

  公式I的化合物，无论是游离形式、盐形式还是溶剂化物形式，其中X、T1、T3和T4的含义如说明书中所指，可用于治疗由ALK-5和/或ALK-4受体介导的疾病。还描述了包含这些化合物的药物组合物以及制备这些化合物的方法。
• Tetrahydropyridly-alkyl-heterocycles, method for preparing same and pharmaceutical compositions containing same
  申请人：——

  公开号：US20040138264A1

  公开（公告）日：2004-07-15

  The present invention relates to compounds of formula (I): 1 in which X represents N or CH; R 1 represents a hydrogen or halogen atom or a CF 3 group; R 2 and R 3 independently represent a hydrogen atom or a methyl group; n is 0 or 1; A represents an optionally substituted nitrogenous heterocycle; and to their N-oxides and to their salts or solvates, to the pharmaceutical compositions and the medicaments comprising them, and to a process for their preparation.

  本发明涉及式(I)的化合物： 其中X代表N或CH；R1代表氢原子或卤素原子或CF3基团；R2和R3分别代表氢原子或甲基基团；n为0或1；A代表一个可选择替代的含氮杂环；以及它们的N-氧化物、盐或溶剂化合物，包括含有它们的药物组合物和药物，以及它们的制备方法。
• [EN] BICYCLIC DERIVATIVES FOR USE IN THE TREATMENT OF ANDROGEN RECEPTOR ASSOCIATED CONDITIONS<br/>[FR] DÉRIVÉS BICYCLIQUES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT D'AFFECTIONS ASSOCIÉES AU RÉCEPTEUR DES ANDROGÈNES
  申请人：ASTRAZENECA AB

  公开号：WO2009081197A1

  公开（公告）日：2009-07-02

  The invention concerns bicyclic compounds of Formula (I), wherein the integers X1, X2, X3, Ring A, R4, R5 and m are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the prevention or treatment of androgen-receptor associated conditions.

  该发明涉及式(I)的双环化合物，其中整数X1、X2、X3、环A、R4、R5和m的定义如描述中所示。本发明还涉及制备这些化合物的方法、含有它们的药物组合物以及它们在制备用于预防或治疗雄激素受体相关疾病的药物中的应用。
• Thiazolyl urea compounds and methods of uses
  申请人：——

  公开号：US20020193405A1

  公开（公告）日：2002-12-19

  Selected novel urea compounds are effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving stoke, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.

  选定的新型尿素化合物对预防和治疗疾病有效，如细胞增殖或凋亡介导的疾病。该发明涵盖了新型化合物、类似物、前药和其药用可接受的盐，以及用于预防和治疗中风、癌症等疾病和其他疾病或病况的药物组合物和方法。该发明还涉及制备此类化合物的方法，以及在这些过程中有用的中间体。
• Nitrogenous tetrahydropyridyl-alkyl-heterocycles with tnf activity
  申请人：Baroni Marco

  公开号：US20050004132A1

  公开（公告）日：2005-01-06

  This invention relates to nitrogenous (tetrahydropyridyl)(alkyl)heterocycles, to pharmaceutical compositions comprising them, to processes for preparing them and to the method of use thereof in the treatment of pain and diseases related to immune and inflammatory disorders.

  这项发明涉及氮杂环（四氢吡啶基）（烷基）杂环化合物，以及包含它们的药物组合物，制备它们的方法以及在治疗疼痛和与免疫和炎症性疾病相关的疾病中使用它们的方法。